Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q3

7459.TEDINET S100Q61E
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥2.57T2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥3.29T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥2.51T2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥37.5bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥37.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥49.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥62.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥51.8bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥56.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥52.2bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥29.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥28.8bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥37.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥36.7bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.81Tat 2022-12-31Cons.Assets
Total assets¥1.71Tat 2022-03-31Cons.Assets
Total assets¥1.78Tat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.13Tat 2022-12-31Cons.Liabilities
Total liabilities¥1.06Tat 2022-03-31Cons.Liabilities
Net assets / equity¥678.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥649.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥649.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥252.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥243.2bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥142.162022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.652022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥137.322021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.092021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥136.42022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥131.412021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥128.872021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio30.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.9%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31¥44m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2022-04-01 → 2022-12-31¥848.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2022-04-01 → 2022-12-31¥847.9bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥253m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.1bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.67T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.66T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥16.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥37.5bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥2.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥2.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31¥391m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥54.8bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥54.8bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥2m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2021-04-01 → 2021-12-31¥802.1bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2021-04-01 → 2021-12-31¥801.8bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥260m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2021-04-01 → 2021-12-31¥20.2bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥1.65T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.65T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥2.6bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥14.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥2.51T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥2.51T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥36.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 384
ItemContextValueUnit
Net salesCurrentYTDDuration2567418000000JPY
Cost of salesPrior1YTDDuration2342689000000JPY
Cost of salesCurrentYTDDuration2396716000000JPY
Gross profitPrior1YTDDuration164581000000JPY
Gross profitCurrentYTDDuration170701000000JPY
Salaries and allowances sgaPrior1YTDDuration55176000000JPY
Salaries and allowances sgaCurrentYTDDuration54424000000JPY
Welfare expenses sgaPrior1YTDDuration9440000000JPY
Welfare expenses sgaCurrentYTDDuration9473000000JPY
Provision for bonuses sgaPrior1YTDDuration3209000000JPY
Provision for bonuses sgaCurrentYTDDuration3332000000JPY
Retirement benefit expenses sgaPrior1YTDDuration2575000000JPY
Retirement benefit expenses sgaCurrentYTDDuration2210000000JPY
Distribution expenses sgaPrior1YTDDuration14174000000JPY
Distribution expenses sgaCurrentYTDDuration14408000000JPY
Rents sgaPrior1YTDDuration3238000000JPY
Rents sgaCurrentYTDDuration3112000000JPY
Depreciation sgaPrior1YTDDuration9234000000JPY
Depreciation sgaCurrentYTDDuration9111000000JPY
Other sgaPrior1YTDDuration30498000000JPY
Other sgaCurrentYTDDuration37096000000JPY
Selling general and administrative expensesPrior1YTDDuration127549000000JPY
Selling general and administrative expensesCurrentYTDDuration133169000000JPY
Operating incomePrior1YTDDuration37031000000JPY
Operating incomeCurrentYTDDuration37531000000JPY
Interest income noiPrior1YTDDuration132000000JPY
Interest income noiCurrentYTDDuration93000000JPY
Dividends income noiPrior1YTDDuration2064000000JPY
Dividends income noiCurrentYTDDuration2041000000JPY
Research fee income noiPrior1YTDDuration6090000000JPY
Research fee income noiCurrentYTDDuration6205000000JPY
Real estate rent noiPrior1YTDDuration1003000000JPY
Real estate rent noiCurrentYTDDuration1494000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration4782000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration2630000000JPY
Other noiPrior1YTDDuration1226000000JPY
Other noiCurrentYTDDuration796000000JPY
Non operating incomePrior1YTDDuration15299000000JPY
Non operating incomeCurrentYTDDuration13262000000JPY
Interest expenses noePrior1YTDDuration13000000JPY
Interest expenses noeCurrentYTDDuration20000000JPY
Rent expenses on real estates noePrior1YTDDuration398000000JPY
Rent expenses on real estates noeCurrentYTDDuration754000000JPY
Other noePrior1YTDDuration77000000JPY
Other noeCurrentYTDDuration110000000JPY
Non operating expensesPrior1YTDDuration489000000JPY
Non operating expensesCurrentYTDDuration884000000JPY
Ordinary incomePrior1YTDDuration51841000000JPY
Ordinary incomeCurrentYTDDuration49908000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration23000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass